Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sodium chloride
Drug ID BADD_D02473
Description Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.
Indications and Usage This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Marketing Status approved; vet_approved
ATC Code A12CA01; B05CB01; B05XA03
DrugBank ID DB09153
KEGG ID D02056
MeSH ID D012965
PubChem ID 5234
TTD Drug ID D04YZL
NDC Product Code 76420-083; 80327-011; 82529-000; 10106-3301; 81861-0026; 82056-0001; 24208-277; 42829-001; 46163-300; 51662-1258; 51879-122; 52584-888; 52584-966; 57826-441; 0338-0160; 63323-093; 63323-187; 63323-632; 63323-924; 65219-222; 0409-1141; 69842-284; 0536-1254; 70529-022; 70529-049; 71872-7084; 79672-613; 80762-0010; 81826-001; 24600-1386; 17271-700; 24208-385; 52584-186; 0264-1800; 0264-2201; 0264-5804; 0264-7805; 0338-9151; 65219-472; 65282-1505; 65282-1510; 0404-9953; 69842-285; 70529-136; 70795-1120; 71872-7248; 76297-001; 80762-0012; 24600-1138; 0990-7730; 11822-0470; 49230-300; 0220-3593; 0220-3597; 0220-3599; 54973-4080; 59390-183; 0338-0047; 63323-623; 65219-226; 65219-468; 65219-474; 0404-9955; 68428-885; 70369-007; 70369-010; 54973-6433; 0338-0054; 62106-5206; 63323-090; 63323-186; 0363-5558; 0363-7500; 65219-470; 0409-1966; 0536-1253; 0641-6144; 73666-0580; 77267-007; 80771-000; 0990-7138; 55579-937; 17478-622; 50090-2488; 0220-3598; 51662-1577; 0264-7802; 58264-0135; 0338-0050; 0338-0051; 0338-0182; 0338-0553; 0338-9543; 0363-1505; 63323-088; 64117-867; 65219-220; 65219-230; 65219-232; 0404-9978; 80327-009; 11014-0075; 24874-0001; 49452-6690; 49452-6700; 0990-7983; 11822-0469; 17271-701; 42829-505; 51662-1318; 0264-7800; 0264-9375; 54973-4095; 55681-305; 0338-0186; 0338-0192; 63323-095; 63323-626; 0363-9050; 0409-4888; 0409-7101; 71872-7083; 73666-0550; 73666-0560; 73666-0570; 14639-6444; 70343-210; 70387-109; 11822-5458; 42829-003; 51662-1464; 0264-7806; 55154-4358; 0338-0162; 0338-0166; 63323-530; 65219-466; 0487-4301; 69626-0064; 69842-533; 70529-021; 76328-100; 10695-153; 24208-276; 0220-3586; 0220-3590; 51662-1342; 51879-191; 0264-5802; 55910-632; 0338-0056; 0338-9159; 65219-218; 65219-432; 67091-327; 70529-024; 71309-154; 0641-0497; 76472-1154; 76472-4096; 77333-835; 77333-844; 0990-6138; 51552-0077; 0990-7972; 0990-7985; 55154-9357; 0338-0048; 0338-0049; 59779-303; 63323-099; 0363-5557; 65219-224; 65219-228; 68428-061; 69842-473; 70529-023; 71872-7082; 0641-1512; 76472-4026; 80762-0011; 10106-3302; 24600-1382; 63822-0001; 51662-1522; 0363-0193; 62106-1058; 63323-139; 64253-202; 0404-9954; 68428-111; 68428-526; 0409-6660; 69842-472; 0990-7984; 69500-110; 70387-115; 17478-623; 42829-407; 42829-504; 49281-912; 0019-1188; 0220-3595; 0220-3600; 52584-109; 55154-0126; 58657-118; 0338-0043; 0338-0164; 0338-0196
UNII 451W47IQ8X
Synonyms Sodium Chloride | Sodium Chloride, (22)Na | Sodium Chloride, (24)NaCl
Chemical Information
Molecular Formula ClNa
CAS Registry Number 7647-14-5
SMILES [Na+].[Cl-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Uterine cancer16.12.05.001; 21.07.02.003---
Uterine leiomyoma16.04.02.001; 21.07.02.004---
Vein disorder24.03.02.015---
Venous thrombosis24.01.01.008---
Ventricular fibrillation02.03.04.0080.000603%
Ventricular tachycardia02.03.04.0100.000362%
Vision blurred06.02.06.007; 17.17.01.010--
Visual acuity reduced06.02.10.012; 17.17.01.011--
Visual field defect06.02.07.003; 17.17.01.0010.000241%-
Visual impairment06.02.10.013---
Vomiting07.01.07.0030.008641%
Wheezing22.03.01.0090.000845%
Mental status changes19.07.01.0010.000845%-
Mobility decreased08.01.03.030; 15.03.05.023; 17.02.05.018---
Multiple sclerosis relapse17.16.01.003---
Cardiotoxicity02.11.01.009; 12.03.01.0070.000241%-
Poor venous access24.03.02.017---
Hypoacusis04.02.01.0060.000362%
Brain oedema12.01.10.010; 17.07.02.0030.000362%
General physical health deterioration08.01.03.018---
Quadriparesis17.01.04.0120.000483%-
Left ventricular hypertrophy02.04.02.0140.000241%-
Muscle tightness15.05.03.007---
Balance disorder08.01.03.081; 17.02.02.007---
Dysstasia08.01.03.089; 15.03.05.011; 17.02.02.012---
Intervertebral disc protrusion15.10.01.004---
Musculoskeletal chest pain15.03.04.012; 22.09.01.001--
Self-injurious ideation19.12.01.007---
Facial paresis17.04.03.0020.000241%
Central nervous system lesion17.02.10.011---
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 17 Pages